Visualizing and Quantifying Acute Inflammation Using ICAM-1 Specific Nanoparticles and MRI Quantitative Susceptibility Mapping

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Annals of Biomedical Engineering

• Publication date

  2011-12-06

• Fields of study

  Medicine, Chemistry, Engineering

• Identifiers
  DOI 10.1007/s10439-011-0482-3PMID 22143599
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tunable physiologic interactions of adhesion molecules for inflamed cell-selective drug delivery.

  2011cited by this paper
• Inflamed leukocyte-mimetic nanoparticles for molecular imaging of inflammation.

  2011cited by this paper
• Nonresolving inflammation.

  2010cited by this paper
• Self-assembled nanoplatform for targeted delivery of chemotherapy agents via affinity-regulated molecular interactions.

  2010cited by this paper
• An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide☆

  2010cited by this paper
• Unambiguous identification of superparamagnetic iron oxide particles through quantitative susceptibility mapping of the nonlinear response to magnetic fields.

  2010cited by this paper
• Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites

  2009cited by this paper
• Pulmonary fibrosis: pathogenesis, etiology and regulation

  2009cited by this paper
• Calculation of susceptibility through multiple orientation sampling (COSMOS): A method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI

  2009cited by this paper
• Yeast Surface Two-hybrid for Quantitative in Vivo Detection of Protein-Protein Interactions via the Secretory Pathway*

  2009cited by this paper
• Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3.

  2008cited by this paper
• Quantifying nanoparticle adhesion mediated by specific molecular interactions.

  2008cited by this paper
• Immunology of asthma and chronic obstructive pulmonary disease

  2008cited by this paper
• Directed evolution to probe protein allostery and integrin I domains of 200,000-fold higher affinity.

  2006cited by this paper
• Noninvasive Vascular Cell Adhesion Molecule-1 Imaging Identifies Inflammatory Activation of Cells in Atherosclerosis

  2006cited by this paper
• From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 23, 2013. For personal use only.

  2006cited by this paper
• In vitro characterization of leukocyte mimetic for targeting therapeutics to the endothelium using two receptors.

  2005cited by this paper
• Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes II: effect of degradation on targeting activity.

  2005cited by this paper
• ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs.

  2005cited by this paper
• Evolving Concepts in the Triad of Atherosclerosis, Inflammation and Thrombosis

  2004cited by this paper
• Molecular Imaging of Factor XIIIa Activity in Thrombosis Using a Novel, Near-Infrared Fluorescent Contrast Agent That Covalently Links to Thrombi

  2004cited by this paper
• Imaging inflammation of the pancreatic islets in type 1 diabetes.

  2004cited by this paper
• Interplay between rolling and firm adhesion elucidated with a cell-free system engineered with two distinct receptor-ligand pairs.

  2003cited by this paper
• Obesity-induced inflammatory changes in adipose tissue.

  2003cited by this paper
• The Effect of Intestinal Ischemia and Reperfusion Injury on ICAM-1 Expression, Endothelial Barrier Function, Neutrophil Tissue Influx, and Protease Inhibitor Levels in Rats

  2002cited by this paper
• Inflammation and cancer

  2002cited by this paper
• Points of control in inflammation

  2002cited by this paper
• Targeted Antiproliferative Drug Delivery to Vascular Smooth Muscle Cells With a Magnetic Resonance Imaging Nanoparticle Contrast Agent: Implications for Rational Therapy of Restenosis

  2002cited by this paper
• Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation.

  2001cited by this paper
• Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care

  2001cited by this paper
• Specific therapy for local and systemic complications of acute pancreatitis with monoclonal antibodies against ICAM-1.

  1999cited by this paper
• Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis.

  1997cited by this paper
• Cytokine‐induced upregulation of hepatic intercellular adhesion molecule‐1 messenger RNA expression and its role in the pathophysiology of murine endotoxin shock and acute liver failure

  1995cited by this paper
• Regional differences in constitutive and induced ICAM-1 expression in vivo.

  1995cited by this paper
• Intercellular adhesion molecule 1 (ICAM‐1) expression and its role in neutrophil‐induced ischemia‐reperfusion injury in rat liver

  1995cited by this paper
• Apical topography and modulation of ICAM-1 expression on activated endothelium.

  1995cited by this paper
• Quantitation of ICAM-1 expression in mouse lung during pneumonia.

  1994cited by this paper
• Multiple organ failure. Pathophysiology and potential future therapy.

  1992cited by this paper
• Cytokines in context

  1991cited by this paper
• Immunohistochemical study of adhesion molecules in liver inflammation

  1990cited by this paper
• Interleukin-6: an overview.

  1990cited by this paper
• Splenectomy alters Kupffer cell response to endotoxin.

  1988cited by this paper
• Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1).

  1987cited by this paper
• Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1).

  1986cited by this paper
• Trypanosoma cruzi: in vitro induction of macrophage microbicidal activity

  1978cited by this paper
• Multiple organ failure.

  1977cited by this paper
• [Inflammation and cancer].

  1974cited by this paper

• MRI Pulse Sequence for Quantifying Magnetic Nanoparticles From Highly Distorted Static Field: View Line

  2024cites this paper
• Refining Nanoprobes for Monitoring of Inflammatory Bowel Disease.

  2024cites this paper
• Nanoscale Contrast Agents for Magnetic Resonance Imaging: A Review

  2022cites this paper
• Characterization of microparticles of iron oxide for magnetic resonance imaging.

  2022cites this paper
• Edge prior guided dictionary learning for quantitative susceptibility mapping reconstruction.

  2021cites this paper
• Iron Mapping Techniques and Applications

  2020cites this paper
• Validation of MRI quantitative susceptibility mapping of superparamagnetic iron oxide nanoparticles for hyperthermia applications in live subjects

  2020cites this paper
• Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy

  2019cites this paper
• Patents on Quantitative Susceptibility Mapping (QSM) of Tissue Magnetism.

  2019cites this paper
• Introduction to quantitative susceptibility mapping and susceptibility weighted imaging.

  2019cites this paper
• Targeted Iron Oxide (Nano)particles Used as MRI Contrast Agent in Small Animal Models

  2018cites this paper
• Establishing the overlap of IONP quantification with echo and echoless MR relaxation mapping

  2018cites this paper
• MEDI+0: Morphology enabled dipole inversion with automatic uniform cerebrospinal fluid zero reference for quantitative susceptibility mapping

  2018cites this paper
• Micromolar affinity CAR T cells to ICAM-1 achieves rapid tumor elimination while avoiding systemic toxicity

  2017cites this paper
• Echo time‐dependent quantitative susceptibility mapping contains information on tissue properties

  2017cites this paper
• Overview of quantitative susceptibility mapping

  2017cites this paper
• Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care

  2017cites this paper
• Affinity-tuning leukocyte integrin for development of safe therapeutics

  2017cites this paper
• Quantitative Susceptibility Mapping (QSM) Algorithms: Mathematical Rationale and Computational Implementations

  2017cites this paper
• Targeting cell adhesion molecules with nanoparticles using in vivo and flow-based in vitro models of atherosclerosis

  2017cites this paper
• Engineering Nanomaterials to Address Cell-Mediated Inflammation in Atherosclerosis

  2016cites this paper
• Quantitative assessment of microvasculopathy in arcAβ mice with USPIO-enhanced gradient echo MRI

  2015cites this paper
• Multiple sclerosis lesion geometry in quantitative susceptibility mapping (QSM) and phase imaging

  2015cites this paper
• Superparamagnetic iron oxide nanoparticle for in vivo molecular and cellular imaging

  2014cites this paper
• Magnetic resonance imaging characterization of microbial infections.

  2014cites this paper
• Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker

  2014cites this paper
• Susceptibility map‐weighted imaging (SMWI) for neuroimaging

  2014cites this paper
• Molecular imaging of bacterial infections in vivo: the discrimination of infection from inflammation

  2014cites this paper
• Specialty area: Emerging Brain Techniques Highlights: 1. QSM quantifies magnetic properties of tissue

  2013cites this paper
• Expression and role of icam-1 in the occurrence and development of hepatocellular carcinoma.

  2013cites this paper
• Bacteria tracking by in vivo magnetic resonance imaging

  2013cites this paper
• Tumor suppression via paclitaxel-loaded drug carriers that target inflammation marker upregulated in tumor vasculature and macrophages.

  2013cites this paper
• Tracking And Quantifying Nanoparticle Contrast Agents Using Magnetic Resonance Imaging

  2012cites this paper